Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials.
Novakovic, A M
Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials. [electronic resource] - Journal of clinical pharmacology 10 2018 - 1284-1294 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1552-4604
10.1002/jcph.1136 doi
Adolescent
Adult
Aged
Disability Evaluation
Disease Progression
Female
Humans
Immunosuppressive Agents--therapeutic use
Lymphocyte Count
Male
Middle Aged
Models, Biological
Multiple Sclerosis--drug therapy
Young Adult
Pharmacometric Analysis of the Relationship Between Absolute Lymphocyte Count and Expanded Disability Status Scale and Relapse Rate, Efficacy End Points, in Multiple Sclerosis Trials. [electronic resource] - Journal of clinical pharmacology 10 2018 - 1284-1294 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1552-4604
10.1002/jcph.1136 doi
Adolescent
Adult
Aged
Disability Evaluation
Disease Progression
Female
Humans
Immunosuppressive Agents--therapeutic use
Lymphocyte Count
Male
Middle Aged
Models, Biological
Multiple Sclerosis--drug therapy
Young Adult